Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D)
Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D)
复制标题
DOI：
10.1016/s0022-3999(99)00004-5
复制
发表时间：
1999-05-01
影响因子：
4.7
通讯作者：
Jacobsen, P
中科院分区：
文献类型：
--
作者：
Hann, D;Winter, K;Jacobsen, P
流行病学研究中心抑郁量表（CES-D）通常用于测量癌症患者的抑郁症状，但当应用于癌症人群时，对该测量的心理测量特性知之甚少。本研究旨在探讨癌症患者CES-D的心理测量学特性。为了进行比较，在接受乳腺癌治疗的女性和没有癌症史的女性中评估了CES-D的心理测量学特性。CES-D和其他研究措施在两种情况下给予接受乳腺癌治疗的女性：治疗前和治疗中期。这些措施也适用于一组年龄与癌症患者相似的妇女，她们没有任何类型的癌症病史。这些健康对照受试者也在两个不同的场合进行了评估。CES-D具有良好的内部一致性，两组的α系数>0.85，两组的重测信度也足够。通过两组之间的比较以及将CES-D与疲劳、焦虑和全球心理健康功能的测量进行比较，以两种方式证明了结构效度。CES-D被确立为乳腺癌患者样本中抑郁症的有效和可靠的测量方法。该方法可能适用于癌症患者的临床心理社会研究，但需要进一步研究以评估其在其他癌症人群中的有用性。强调了用已在癌症患者中验证的标准措施测量心理症状的重要性。(C)1999 Elsevier Science Inc.
The Center for Epidemiological Studies Depression Scale (CES-D) is commonly used to measure depressive symptomatology in cancer patients, yet there is little known about the psychometric properties of the measure when applied to a cancer population. The aim of this study was to examine the psychometric properties of the CES-D with cancer patients. For purposes of comparison, the psychometric properties of the CES-D were assessed both in women undergoing treatment for breast cancer and women with no history of cancer. The CES-D and other study measures were administered to women undergoing treatment for breast cancer on two occasions: prior to treatment and midway through treatment. The measures were also administered to a group of women similar in age to the cancer patients who had no history of any type of cancer. These healthy comparison subjects were also assessed on two separate occasions. The CES-D was found to have good internal consistency, with alpha coefficients >0.85 for both groups, as well as adequate test-retest reliability in both groups. Construct validity was demonstrated in two ways, via comparisons between the groups and by comparing the CES-D with measures of fatigue, anxiety, and global mental health functioning. The CES-D was established as a valid and reliable measure of depressive symptomatology in this sample of breast cancer patients This measure may be appropriate for use in clinical psychosocial research with cancer patients, yet further research is needed to evaluate its usefulness in other cancer populations. The importance of measuring psychological symptoms with standard measures that have been validated with cancer patients is highlighted. (C) 1999 Elsevier Science Inc.